American health care creates no incentive for pharma companies to cure diseases. When you cure a disease, the customers go away. There's no money in that. Curing patients is not a sustainable business model, per Goldman Sachs. news.slashdot.org/story/19/02/...
Post
Sovaldi was available in December 2013. Hovaldi was available in October 2014. Hovaldi was not the first cure for HepC.
0 reposts0 likes
No replies yet.